A first-of-its-kind law taking effect in December 2025 in New York state means more transparency around diaper ingredients ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
Snopes readers regularly ask whether supplement brands like Neurocept and Burn Peak are legit. Here's how you can tell yourself.
Zacks Investment Research on MSN
Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now?
Bristol Myers Squibb BMY and Gilead Sciences, Inc. GILD are leading biotechnology companies with broad, diverse portfolios and a global footprint. BMY boasts a strong portfolio with drugs for oncology ...
Two experimental oral obesity medicines from Novo Nordisk and Eli Lilly are moving toward potential FDA approval, raising legal and public-interest questions about access, regulatory oversight, and ...
NEW YORK – The US Food and Drug Administration on Tuesday released a proposal to reclassify companion diagnostic assays from Class III medical devices to Class II devices. In its proposal in the ...
The Trump administration designated Cartel de los Soles, which it claims is headed by Venezuelan President Nicolás Maduro, a foreign terrorist organization as the Trump administration indicates it ...
Bristol Myers Squibb BMY recently announced that it will discontinue the late-stage Librexia study on cardiovascular candidate milvexian, an investigational oral, highly selective factor XIa (FXIa) ...
Tarlatamab-dlle received FDA approval for ES-SCLC after showing a 40% reduction in death risk compared with chemotherapy in the DeLLphi-304 trial. The trial demonstrated improved overall survival ...
Sevabertinib received accelerated FDA approval for HER2 TKD-mutant nonsquamous NSCLC, showing a 71% ORR in the SOHO-01 trial. The treatment demonstrated a tolerable safety profile, with diarrhea as ...
Cytokinetics may be counting down the days until the FDA decides whether to approve its cardiovascular drug aficamten. But, for a biotech planning to commercialize its first drug—and without Big ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The FDA has restricted the type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback